1. Methods behind clinical DC vaccine products against glioblastoma Rüdiger V. Sorg 2. Fully closed and automated isolation of natural blood dendritic cells for cancer immunotherapy Jolanda de Vries and Gerty Schreibelt 3. Methods behind Oncolytic virus-based DC vaccines in cancer: towards a multiphase combined treatment strategy for Glioblastoma (GBM) patients Stefaan W. Van Gool 4. Identification of TCR repertoire patterns linked with anti-cancer immunotherapy Kris Laukens and Romi Vandoren 5. Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells Eva Lion and Kris Laukens 6. Methods behind neoantigen predictions for anticancer vaccines Cedric Bogaert 7. Methods behind CD137L-DC-EBV-VAX anticancer vaccine Herbert Schwarz 8. Gold Standard Assessment of Immunogenic Cell Death Induced by Photodynamic Therapy: From In Vitro to Tumor Mouse Models and Anti-Cancer Vaccination Strategies Dmitri Krysko 9. Methods behind TCR analyses for colorectal cancer-associated TILs Sara Verbandt, Ting Pu and Sabine Tejpar 10. The use of xCELLigence, Incucyte, and/or Cr/LDH/maker-release assays Adam Snook 11. Humanized mouse models for anti-cancer therapy Eleonora Leucci 12. In vitro re-challenge of CAR T cells Sebastien Walchli and Alicia Villatoro 13. Methods behind adoptively transferred tumor draining lymphocytes? for anticancer immunotherapy Harry D. Bear and Carolyn Haynes 14. A murine glioblastoma platform to test cellular therapies with the standard of care An Coosemans and Aaron Ziani Zeryouh Jr.